Modified antibodies overview

11 Mar 2021

In this application note, Biorbyt highlights the differences between recombinant, therapeutic, bispecific, and labeled antibodies and explains how modified antibodies are produced.

CD133 antibody

Biorbyt

Rabbit polyclonal antibody to CD133; which is also known as prominin or AC133. CD133 is a marker frequently found on multipotent progenitor cells; including immature hematopoietic stem and progenitor cells. The protein has been extensively used as a stem cell marker for normal and cancerous tissues.

(2)

Links

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Therapeutic AntibodiesTherapeutic antibodies are antibodies engineered for use in treating diseases. They can be designed to target specific antigens, blocking harmful interactions or modulating immune responses. Therapeutic antibodies are critical in treating conditions like cancer, autoimmune disorders, and infectious diseases. Explore the best therapeutic antibody products in our peer-reviewed product directory; compare options, check reviews, and get pricing directly from manufacturers.
Modified antibodies overview